Financial Consultant: Roger Humm
Roger is an experienced Commercial and Finance Director with extensive knowledge of technology companies and start-up businesses. With a first degree in Microbiology & Virology, he qualified as a chartered accountant in 1984, and completed his MBA in 1997. Roger has been finance director and commercial director for businesses of diverse sizes across a broad-range of market sectors, has managed a portfolio of trade investments and has held non-executive director positions with various early-stage companies, including Oxford BioSignals, Oxford Diffraction and ARKeX.
Clinical Consultant: Professor David Matthews
David is Professor of Diabetic Medicine at the University of Oxford and Chairman of the Oxford Centre for Diabetes, Endocrinology and Metabolism, and divides his time between research, teaching and clinical care. He advises the company on clinical matters including the design and execution of the clinical trials to test the safety and efficacy of needle-free delivery of glucagon with the Particle Therapeutics Device.